obesity drug news today glp-1 september 29 2025 There's lots going on this month at FDA in the world of weight loss drugs. The agency is taking a hard look at the market. Check out these new #FDA Warning Letters GLP-1 Agonists Market Report 2025-2033,

GLP-1 Pipeline Update: November 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid

"We're really pushing hard to get into that second position behind orforglipron, now Foundayo." Pfizer also unveiled mid-stage data from a shot it gained through its $10 billion acquisition of Metsera

Black people are disproportionately likely to live in Southern states, which as a region has a higher prevalence of obesity and lower income when compared to the rest of the country

A clinician might say: Because you already take metformin, adding a GLP-1RA can help your weight and heart health without causing low blood sugar

Zhong, W

Patients in Dubai and Abu Dhabi can access these options after a consultation with our endocrinologist, with the standard support: free medication delivery (no markup), monthly follow-ups, body-composition tracking on every visit, and ongoing lifestyle coaching